B

Bioatla Inc
NASDAQ:BCAB

Watchlist Manager
Bioatla Inc
NASDAQ:BCAB
Watchlist
Price: 1.72 USD 0.58%
Market Cap: 83.1m USD
Have any thoughts about
Bioatla Inc?
Write Note

Bioatla Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bioatla Inc
Depreciation & Amortization Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
B
Bioatla Inc
NASDAQ:BCAB
Depreciation & Amortization
$1.2m
CAGR 3-Years
7%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Depreciation & Amortization
$8.4B
CAGR 3-Years
-1%
CAGR 5-Years
34%
CAGR 10-Years
27%
Gilead Sciences Inc
NASDAQ:GILD
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Depreciation & Amortization
$5.6B
CAGR 3-Years
18%
CAGR 5-Years
23%
CAGR 10-Years
11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Depreciation & Amortization
$208.6m
CAGR 3-Years
20%
CAGR 5-Years
16%
CAGR 10-Years
12%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Depreciation & Amortization
$469.5m
CAGR 3-Years
20%
CAGR 5-Years
19%
CAGR 10-Years
25%

See Also

What is Bioatla Inc's Depreciation & Amortization?
Depreciation & Amortization
1.2m USD

Based on the financial report for Dec 31, 2023, Bioatla Inc's Depreciation & Amortization amounts to 1.2m USD.

What is Bioatla Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
9%

Over the last year, the Depreciation & Amortization growth was 2%. The average annual Depreciation & Amortization growth rates for Bioatla Inc have been 7% over the past three years , 9% over the past five years .

Back to Top